MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) Institutional Ownership
What the institutions did with MLTX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| BVF INC/IL | 16.0M | 21.8% |
| Deep Track Capital, LP | 7.0M | 9.5% |
| T. Rowe Price Investment Management, Inc. | 4.3M | 5.8% |
| D. E. Shaw & Co., Inc. | 3.4M | 4.6% |
| Cormorant Asset Management, LP | 3.2M | 4.4% |
| Jupiter Topco LLC | 3.1M | 4.2% |
| Logos Global Management LP | 2.7M | 3.6% |
| Weiss Asset Management LP | 2.6M | 3.5% |
| CITADEL ADVISORS LLC | 2.0M | 2.7% |
| TWO SIGMA INVESTMENTS, LP | 1.7M | 2.3% |
| MPM BIOIMPACT LLC | 1.6M | 2.2% |
| Vivo Capital, LLC | 1.4M | 1.9% |
| JPMORGAN CHASE & CO | 1.4M | 1.9% |
| Point72 Asset Management, L.P. | 1.2M | 1.6% |
| BlackRock, Inc. | 1.1M | 1.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.0M | 1.4% |
| Balyasny Asset Management L.P. | 912.7K | 1.2% |
| GREAT POINT PARTNERS LLC | 855.8K | 1.2% |
| JANE STREET GROUP, LLC | 853.4K | 1.2% |
| Candriam S.C.A. | 769.8K | 1.0% |
| BANK OF AMERICA CORP /DE/ | 751.9K | 1.0% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 750.8K | 1.0% |
| Trails Edge Capital Partners, LP | 750.0K | 1.0% |
| HRT FINANCIAL LP | 679.2K | 0.9% |
| RENAISSANCE TECHNOLOGIES LLC | 643.3K | 0.9% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | New | 0 | 4.3M | +4.3M |
| Cormorant Asset Management, LP | Reduced | 4.5M | 3.2M | -1.3M |
| Logos Global Management LP | Increased | 1.5M | 2.7M | +1.2M |
| GOLDMAN SACHS GROUP INC | Reduced | 1.1M | 129.4K | -1.0M |
| D. E. Shaw & Co., Inc. | Increased | 2.4M | 3.4M | +974.8K |
| Weiss Asset Management LP | Increased | 1.7M | 2.6M | +873.5K |
| Trails Edge Capital Partners, LP | New | 0 | 750.0K | +750.0K |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 70.1K | 750.8K | +680.6K |
| CITADEL ADVISORS LLC | Increased | 1.3M | 2.0M | +649.2K |
| TWO SIGMA INVESTMENTS, LP | Increased | 1.1M | 1.7M | +593.0K |
| Deep Track Capital, LP | Increased | 6.4M | 7.0M | +590.2K |
| Jefferies Financial Group Inc. | Sold Out | 500.0K | 0 | -500.0K |
| Qube Research & Technologies Ltd | Increased | 42.9K | 496.2K | +453.3K |
| Casdin Capital, LLC | Sold Out | 450.0K | 0 | -450.0K |
| MARSHALL WACE, LLP | Increased | 111.3K | 550.4K | +439.0K |
| ADAR1 Capital Management, LLC | Reduced | 457.1K | 27.0K | -430.1K |
| Vivo Capital, LLC | Increased | 1.0M | 1.4M | +400.0K |
| JANE STREET GROUP, LLC | Increased | 453.6K | 853.4K | +399.8K |
| Capricorn Fund Managers Ltd | New | 0 | 374.9K | +374.9K |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 276.8K | 643.3K | +366.5K |
| GREAT POINT PARTNERS LLC | Increased | 500.0K | 855.8K | +355.8K |
| Holocene Advisors, LP | Reduced | 600.0K | 250.0K | -350.0K |
| UBS Group AG | Increased | 3.9K | 328.5K | +324.6K |
| First Turn Management, LLC | Sold Out | 315.6K | 0 | -315.6K |
| AQR CAPITAL MANAGEMENT LLC | Increased | 46.2K | 358.9K | +312.7K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.